Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Iron, oxidative stress, and redox signaling in the cardiovascular system
Aurélie Gudjoncik, Charles Guénancia, Marianne Zeller, et al.
Molecular Nutrition & Food Research (2014) Vol. 58, Iss. 8, pp. 1721-1738
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis
Luc Rochette, Geoffrey Dogon, Eve Rigal, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 449-449
Open Access | Times Cited: 360
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette, Charles Guénancia, Aurélie Gudjoncik, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 6, pp. 326-348
Open Access | Times Cited: 229
BRD4770 functions as a novel ferroptosis inhibitor to protect against aortic dissection
Yue Chen, Xin Yi, Bo Huo, et al.
Pharmacological Research (2022) Vol. 177, pp. 106122-106122
Open Access | Times Cited: 104
Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
Wenhui Tao, Xi-sheng Shan, Jiaxin Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 71
Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
Konrad Teodor Sawicki, Adam De Jesus, Hossein Ardehali
Circulation Research (2023) Vol. 132, Iss. 3, pp. 379-396
Open Access | Times Cited: 64
Trace minerals intake: Risks and benefits for cardiovascular health
Noushin Mohammadifard, Karin H. Humphries, Carolyn Gotay, et al.
Critical Reviews in Food Science and Nutrition (2017) Vol. 59, Iss. 8, pp. 1334-1346
Closed Access | Times Cited: 131
Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets
Luc Rochette, Marianne Zeller, Yves Cottin, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 12, pp. 939-951
Open Access | Times Cited: 116
Eryptosis in health and disease: A paradigm shift towards understanding the (patho)physiological implications of programmed cell death of erythrocytes
Syed M. Qadri, Rosi Bissinger, Ziad Solh, et al.
Blood Reviews (2017) Vol. 31, Iss. 6, pp. 349-361
Closed Access | Times Cited: 113
Iron deficiency beyond erythropoiesis: should we be concerned?
Khaled M. Musallam, Alì Taher
Current Medical Research and Opinion (2017) Vol. 34, Iss. 1, pp. 81-93
Closed Access | Times Cited: 108
GDF15 and Cardiac Cells: Current Concepts and New Insights
Luc Rochette, Geoffrey Dogon, Marianne Zeller, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8889-8889
Open Access | Times Cited: 97
Eryptosis as a marker of Parkinson's disease
Etheresia Pretorius, Albe C. Swanepoel, Antoinette V. Buys, et al.
Aging (2014) Vol. 6, Iss. 10, pp. 788-819
Open Access | Times Cited: 91
The iron-regulatory hormone hepcidin: A possible therapeutic target?
Luc Rochette, Aurélie Gudjoncik, Charles Guénancia, et al.
Pharmacology & Therapeutics (2014) Vol. 146, pp. 35-52
Open Access | Times Cited: 85
Chronic iron overload intensifies atherosclerosis in apolipoprotein E deficient mice: Role of oxidative stress and endothelial dysfunction
Vinícius Bermond Marques, Marcos André Soares Leal, Jandinay Gonzaga Alexandre Mageski, et al.
Life Sciences (2019) Vol. 233, pp. 116702-116702
Open Access | Times Cited: 70
Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways
Milad Ashrafizadeh, Ali Zarrabi, Sedigheh Saberifar, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 110-110
Open Access | Times Cited: 63
Oxidative Stress-Related Endothelial Damage in Vascular Depression and Vascular Cognitive Impairment: Beneficial Effects of Aerobic Physical Exercise
Maria Luca, Antonina Luca
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-6
Open Access | Times Cited: 55
GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism
Luc Rochette, Marianne Zeller, Yves Cottin, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 11, pp. 875-889
Open Access | Times Cited: 44
Fluoxetine ameliorates Alzheimer’s disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2/HO-1 and hindering TLR4/NLRP3 inflammasome signaling pathway
Karema Abu‐Elfotuh, Aya H. Al‐Najjar, Asmaa A. Mohammed, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108488-108488
Closed Access | Times Cited: 34
Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction
Ting Ye, Wei Yang, Tielei Gao, et al.
Free Radical Biology and Medicine (2023) Vol. 206, pp. 143-161
Open Access | Times Cited: 20
The Crosstalk of Adipose-Derived Stem Cells (ADSC), Oxidative Stress, and Inflammation in Protective and Adaptive Responses
Luc Rochette, Loubna Mazini, Gabriel Malka, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9262-9262
Open Access | Times Cited: 49
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection
Luc Rochette, Stéliana Ghibu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7979-7979
Open Access | Times Cited: 36
Interplay between efferocytosis and atherosclerosis
Luc Rochette, Geoffrey Dogon, Eve Rigal, et al.
Archives of cardiovascular diseases (2023) Vol. 116, Iss. 10, pp. 474-484
Closed Access | Times Cited: 13
Chronic iron overload in rats increases vascular reactivity by increasing oxidative stress and reducing nitric oxide bioavailability
Vinícius Bermond Marques, Tatiani Botelho Nascimento, Rogério Faustino Ribeiro Júnior, et al.
Life Sciences (2015) Vol. 143, pp. 89-97
Closed Access | Times Cited: 48
Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues
Rodrigo Valenzuela, Miguel Ángel Rincón‐Cervera, Francisca Echeverría, et al.
Nutrition (2017) Vol. 45, pp. 49-58
Closed Access | Times Cited: 43
Iron Overload Damages the Endothelial Mitochondria via the ROS/ADMA/DDAHII/eNOS/NO Pathway
Huan He, Qiao Yang, Qing Zhou, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-19
Open Access | Times Cited: 41
Dual action of vitamin C in iron supplement therapeutics for iron deficiency anemia: prevention of liver damage induced by iron overload
Huan He, Qiao Yang, Zeyu Zhang, et al.
Food & Function (2018) Vol. 9, Iss. 10, pp. 5390-5401
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top